Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma
(1) Background: In clinical settings, data regarding sex are rarely investigated. In women, factors such as body size and composition, hormonal variations, metabolism, and access to care systems and therapy could strongly influence the pharmacological management and the outcome of the therapy. To un...
Main Authors: | Sarah Allegra, Soraya Puglisi, Irene Brescia, Francesco Chiara, Vittoria Basile, Anna Calabrese, Giuseppe Reimondo, Silvia De Francia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/3/266 |
Similar Items
-
Cibles moléculaires du Mitotane : Implications pour le traitement du corticosurrénalome
by: Hescot, Ségolène
Published: (2015) -
Toxicologically important DDT metabolites : Synthesis, enantioselective analysis and kinetics
by: Cantillana, Tatiana
Published: (2009) -
Enantiomeric composition of Chiral pesticides in soil and air from the U.S. cornbelt region
by: Leone, Andrea D.
Published: (1998) -
Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer
by: Vittoria Basile, et al.
Published: (2020-09-01) -
Adrenal Bioactivation and Toxicity of 3-MeSO2-DDE, o,p´-DDD and DMBA Investigated in Tissue Slice Culture
by: Lindhe, Örjan
Published: (2001)